NEW YORK –Sophia Genetics and ADC Therapeutics of Lausanne, Switzerland, said today that they will collaborate to identify genomic markers associated with clinical response to an experimental lymphoma treatment.
To read the full story....
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.